News

RAPAFLO, a selective alpha-1 adrenergic receptor antagonist, maximizes target organ activity by binding with high affinity to the alpha (1A) receptors concentrated in the prostate. The double-blind, 12-week,

The company expects to recruit around 880 patients in 48 hospitals in 9 countries across three continents. The study, named as immunotherapy Multikine anti tumor treatments (IT-MATTERS), is

OHR/AVR118 an immunomodulator which modulates cellular pro-inflammatory chemokine and cykotine synthesis, including tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). The company said OHR/AVR118 has powerful chemoprotective effects which

PharmaNet is a provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device industries and provides capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence

CT-011, an experimental anti-PD-1 monoclonal antibody, has also achieved secondary endpoint of overall survival (OS) in the Phase II trial. Initial analysis demonstrated that 70% of the patients

Originally developed by Roxro Pharma, Sprix is a prescription intranasal formulation of the analgesic ketorolac, a non-steroidal anti-inflammatory drug (NSAID). The spray is packaged in boxes that comprises

GBI is a cGMP contract manufacturer of monoclonal antibodies, recombinant proteins and vaccines. GBI also offers process development services from proof of concept and preclinical through phase II

Risperidone is an atypical antipsychotic that works by affecting certain substances in the brain. Risperidone tablets and Oral Solution are indicated for the treatment of schizophrenia. Alendronate tablets

Among the three products, two products have been transferred for pilot manufacturing and the remaining one product for full scale commercial manufacturing. Under the agreement, Teva will use